1. Huang CH*, Yang WH*, Chang SY, Tai SK, Tzeng CH, Kao JY, Wu KJ and Yang MH. Regulation
of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.
Neoplasia 2009;11:1371-82.
2. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ, Hung MC and Yang MH.
RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol. 2012; 14:366-74.
3. Yang WH, Su YH, Hsu WH, Wang CC, Arbiser L. J and Yang MH. Imipramine blue halts head and
neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1
degradation. Oncogene 2016; 35:2287-98.
4. Yang WH*, Cha JH*, Xia W, Lee HH, Chan LC, Wang YN, Hsu JL, Ren GX and Hung MC.
Juxtacrine signaling inhibits antitumor immunity via upregulating PD-L1. Cancer Research 2018;
78(14):3761-3768.
5. Cha JH*, Yang WH*, Xia W, Wei Y, Chan LC, Lim SO, Li CW, Kim T, Chang SS, Lee HH, Hsu J,
Wang HL, Kuo CW, Chang WC, Hadad S, Purdie CA, McCoy AM, Cai S, Tu Y, Litton JK, Mittendorf EA,
Moulder SL, Symmans WF, Thompson AM, Piwnica-Worms H, Chen CH, Khoo KH and Hung MC.
Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1.
Molecular Cell 2018; 71(4):606-620.e7.